Lama Vibha N, Murray Susan, Mumford Jeanette A, Flaherty Kevin R, Chang Andrew, Toews Galen B, Peters-Golden Marc, Martinez Fernando J
Division of Pulmonary and Critical Care Medicine, Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, 48109-0360, USA.
Am J Respir Crit Care Med. 2005 Aug 1;172(3):379-83. doi: 10.1164/rccm.200501-097OC. Epub 2005 May 13.
Early diagnosis of bronchiolitis obliterans syndrome (BOS) is critical in understanding pathogenesis and devising therapeutic trials. Although potential-BOS stage (BOS 0-p), encompassing early changes in FEV(1) and forced expiratory flow, midexpiratory phase (FEF(25-75%)), has been proposed, there is a paucity of data validating its utility in single-lung transplantation.
The aim of this study was to define the predictive ability of BOS 0-p in single-lung transplantation.
We retrospectively analyzed spirometric data for 197 single-lung recipients. Sensitivity, specificity, and positive predictive value of BOS 0-p were examined over time using Kaplan-Meier methodology.
BOS 0-p FEV(1) was associated with higher sensitivity, specificity, and positive predictive value than the FEF(25-75%) criterion over different time periods investigated. The probability of testing positive for BOS 0-p FEV(1) in patients with BOS (sensitivity) was 71% at 2 years before the onset of BOS. The probability of being free from development of BOS 0-p FEV(1) in patients free of BOS at follow-up (specificity) was 93% within the last year. Of patients who met the BOS 0-p FEV(1) criterion, 81% developed BOS or died within 3 years. The specificity and positive predictive value curves for the BOS 0-p FEV(1) were significantly different between patients with underlying restrictive versus obstructive physiology (p = 0.05 and 0.01, respectively).
The FEV(1) criterion for BOS 0-p provides useful predictive information regarding the risk of development of BOS or death in single-lung recipients. The predictive value of this criterion is higher in patients with underlying restriction and is superior to the FEF(25-75%) criterion.
闭塞性细支气管炎综合征(BOS)的早期诊断对于理解其发病机制和开展治疗试验至关重要。尽管有人提出了潜在BOS阶段(BOS 0-p),包括第一秒用力呼气容积(FEV(1))和用力呼气流量、呼气中期(FEF(25-75%))的早期变化,但在单肺移植中验证其效用的数据却很匮乏。
本研究旨在明确BOS 0-p在单肺移植中的预测能力。
我们回顾性分析了197名单肺移植受者的肺功能数据。使用Kaplan-Meier方法随时间检查BOS 0-p的敏感性、特异性和阳性预测值。
在不同研究时间段内,与FEF(25-75%)标准相比,BOS 0-p的FEV(1)具有更高的敏感性、特异性和阳性预测值。在BOS发病前2年,BOS患者中BOS 0-p的FEV(1)检测呈阳性的概率(敏感性)为71%。在随访中无BOS的患者中,在最后一年内无BOS 0-p的FEV(1)发生的概率(特异性)为93%。符合BOS 0-p的FEV(1)标准的患者中,81%在3年内发生了BOS或死亡。潜在限制性生理与阻塞性生理的患者之间,BOS 0-p的FEV(1)的特异性和阳性预测值曲线存在显著差异(分别为p = 0.05和0.01)。
BOS 0-p的FEV(1)标准为单肺移植受者发生BOS或死亡的风险提供了有用的预测信息。该标准在潜在限制性患者中的预测价值更高,且优于FEF(25-75%)标准。